Detalhe da pesquisa
1.
Etoposide combined with cytarabine and pegfilgrastim for poorly mobilizing patients with multiple myeloma and lymphoma: A prospective multicentre study.
Br J Haematol;
204(6): 2342-2350, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38400570
2.
Higher efficacy of Etoposide + Cytarabine Plus Pegfilgrastim in poorly mobilizing Multiple Myeloma and lymphoma Patients.
Cytotherapy;
25(8): 885-890, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37212754
3.
Loss of IRF8 inhibits the growth of acute myeloid leukemia cells.
Ann Hematol;
102(5): 1063-1072, 2023 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36959484
4.
Dihydropyrimidinase-like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia.
Cancer Med;
12(7): 8319-8330, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36621846
5.
Primary refractory diffuse large B-cell lymphoma of the uterine cervix, secondary kidney tumor: A case report.
Asian J Surg;
2024 May 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38724357